Skip to content

Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms

Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms (MOMS-AD Pilot Study)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07485036
Acronym
MOMS-AD
Enrollment
30
Registered
2026-03-20
Start date
2026-06-01
Completion date
2027-11-30
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use, Contingency Management, Postpartum Depression (PPD), Problem Solving Therapy

Brief summary

This study aims to learn about depression and alcohol use in postpartum mothers and whether an intervention based on contingency management and problem-solving therapy (CM-PST) can help reduce these symptoms. The main questions it seeks to answer are: 1. How do new mothers fare with depressive symptoms and alcohol use in the first 12 months after giving birth? 2. Will a CM-PST intervention reduce depressive symptoms and alcohol use frequency among new mothers? 3. Is a CM-PST intervention practical for new mothers? The researchers will recruit approximately 30 new mothers and randomly select half to attend a 6-week CM-PST intervention. They will compare those who received the intervention versus those who did not to see if there are any differences in their depressive symptoms and alcohol usage. Participants will: * Complete 4 remote intervention sessions over 6 weeks * Conduct at-home urine drug tests 2x per week during the 6-week intervention * Answer online surveys about their mental health and alcohol use

Interventions

BEHAVIORALContingency Management & Problem Solving Therapy

A 6-week online CM-PST course delivered through video conferencing calls consisting of 4 educational sessions, combined with 2x weekly at-home drug testing to monitor the reduction in alcohol use and reduced depression symptoms.

OTHERUsual Care

Participants randomized to the usual care condition will continue to receive standard postpartum care from their obstetrician-gynecologist, consistent with routine clinical practice. No additional psychological intervention will be provided as part of the study.

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Biologically female * Age ≥18 years * Within 12 months postpartum * Able to provide informed consent

Exclusion criteria

* Serious medical or psychiatric conditions requiring hospitalization * Lifetime DSM-5 diagnosis of schizophrenia, bipolar disorder, or any psychiatric disorder * Current use of psychoactive drugs, medication to treat problematic alcohol use, or depression * Participation in past 6 months in problematic alcohol use or substance use treatment * Unable to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Change in postpartum depression symptomsScreening, Baseline, 3 monthsParticipants will take the Edinburgh Postnatal Depression Scale (EPDS) at screening, baseline and at 3 months to assess changes in mental health and depressive symptoms. This is reported on a scale of 0-30; a higher score indicates a higher likelihood of postpartum depression.
Alcohol use test resultsBaseline, Weekly, 3 monthsParticipants' alcohol use will be monitored and assessed with urine drug tests at baseline, 2x weekly throughout the duration of the 6-week intervention, and at 3 months.
Change in alcohol use screening statusScreening, Baseline, 3 monthsParticipants will take the Alcohol Use Disorders Identification Test (AUDIT) at the time of screening, baseline and at 3 months. This is reported on a scale of 0-40; a higher score indicates a higher likelihood of moderate to severe alcohol use.
Change in alcohol-related negative consequencesBaseline, 3 monthsParticipants will take the Rutgers Alcohol Problems Index (RAPI) at baseline and at 3 months to assess changes in problems related to alcohol use. This is reported on a scale of 0-72; a higher score indicates a higher likelihood of alcohol-related negative consequences in everyday life.
Change in alcohol useBaseline, 3 monthsParticipants will take the Timeline Follow Back (TLFB) questionnaire at baseline and at 3 months to assess changes in alcohol use.
Change in reasons for drinkingBaseline, 3 monthsParticipants will take the Drinking Motive Questionnaire-Revised (DMQ-R) at baseline and at 3 months to assess changes in alcohol use motivations. This is reported on a scale of 20-100; a higher score indicates stronger motivations for alcohol use.

Secondary

MeasureTime frameDescription
Acceptability of intervention3 monthsParticipants will complete a 10-minute interview at the end of the intervention to assess their sentiments towards CM-PST and take the Client Counseling Satisfaction Scale (CCSS). This is reported on a five-point Likert scale of 6-30, and includes an open-ended question about suggestions for future interventions. A higher score indicates a higher likelihood of participant satisfaction.
Feasibility of intervention via adherence3 monthsParticipant adherence will be assessed by monitoring and documenting attendance for each intervention session and completion of urine alcohol screening tests.
Feasibility of intervention via retention3 monthsParticipant retention will be assessed by monitoring and calculating the proportion of the study sample retained by the end of the intervention.

Countries

United States

Contacts

CONTACTHagar Hallihan, PhD, RN
hhalli2@uic.edu312-413-5361

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026